Patent ID: 6706892
Filing Date: 2004-03-16
Classification: A61K,A61P

Abstract:
A pharmaceutical composition comprising a compound selected from the group consisting of:a) 2-[2-[4-[(4-chlorophenyl)phenylmethyl[-1-piperazinyl]ethoxy]-maleimido-ethylacetamide; b) 11-(N-maleimidopropionyl-4-piperidylidene)-8-chloro-6,11-dihydro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine; c) N-(2-maleimidoethyl)-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-prolinylamide; d) N-[2-maleimidoethyl-&egr;-(3,4,5-trimethoxybenzamido)-caproic amide; e) Maleimidoethyl-1-theobromineacetamide; f) N-(2-maleimidoethyl)-2-[4-(2-oxocyclopentan-1-ylmethyl)phenyl]-propionamide; g) N-maleimidopropionyl-N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; h) 4-[N-phenyl-3-maleimidopropionamido]-1-(2-phenylethyl)piperidine; and i) N-(2-maleimidoethyl-3,5-3â€²,5â€² tetraiodothyroninamide.